Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
MyShell has been selected as one of the top 20 start-up companies in the open-source field globally for 2024

MyShell has been selected as one of the top 20 start-up companies in the open-source field globally for 2024

Bitget2025/03/27 08:34

According to TechCrunch, the AI Agent platform MyShell has been selected as one of the top 20 startups in the global open-source field for 2024.

The TTS model OpenVoice developed by the MyShell team has received widespread attention from the open-source AI community and has garnered over 31,500 stars and more than 3,200 forks on GitHub. With its extensive and deep technical accumulation in the AI field, MyShell ranks 11th globally on the list.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

SQM.US Q3 profit misses expectations; lithium price declines but demand outlook remains “encouraging”

SQM.US still reports seeing "encouraging" potential demand trends.

智通财经•2026/11/18 03:16

Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

According to a report by Mizuho Securities analysts, following a series of recent system failures in the United States, consumers have started stockpiling essential goods, leading to a short-term surge in demand for Costco, a members-only retailer.

智通财经•2026/11/18 03:07
Mizuho: Consecutive system outages in the US trigger stockpiling surge! With short-term demand boosted, Costco (COST.US) sales momentum is expected to remain strong.

Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Biogen has released the latest interim clinical trial data for its early-stage Alzheimer's disease candidate drug, diranersen.

智通财经•2026/11/18 03:02
Biogen (BIIB.US) announces mid-stage trial data for early Alzheimer's candidate drug diranersen: significant slowing of clinical decline over two years

Nvidia Acting CEO Kress Reassures the Market: No Customer Loss and No Employee Exodus

Nvidia released its first quarterly financial report since Jensen Huang's resignation, after which Colette Kress told the media that major client demand has not been affected and the workforce remains stable, emphasizing that "everything is business as usual." The company's share price rose over 3% after hours, though the stock is still down 24% for the month.

华尔街见闻•2026/11/18 02:41